The Seattle Seahawks, Super Bowl Winners, Go Up for Sale

西雅图海鹰队,超级碗冠军,将挂牌出售。

WSJ What’s News

2026-02-19

13 分钟
PDF

单集简介 ...

P.M. Edition for Feb. 18. A long-anticipated sale of the Seattle Seahawks is now underway—and the sale price could break NFL records. Plus, Stephen Hemsley, the leader of UnitedHealth Group, for years made private investments in healthcare startups. Journal senior editor Mark Maremont digs into how some of those companies also did business with, or competed against, UnitedHealth. And in his testimony at a landmark social media trial, Meta CEO Mark Zuckerberg defended the company’s practices. Alex Ossola hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
更多

单集文稿 ...

  • Meta CEO Mark Zuckerberg testifies at a landmark social media trial.

  • Plus, the leader of UnitedHealth privately invested millions of dollars in companies,

  • including firms that compete with UnitedHealth.

  • His investment company, which is called Cloverfield's Capital, has this public-facing side.

  • They invest in publicly traded stocks.

  • What we found is that there's a completely different side of Clover Fields,

  • which was really doing this venture capital investing in the healthcare industry on the quiet.

  • And who wants to buy a Super Bowl champion team?

  • It's Wednesday, February 18th.

  • I'm Alex O'Sulliv for the Wall Street Journal.

  • This is the PM edition of What's News,

  • the top headlines and business stories that move the world today.

  • Meta CEO Mark Zuckerberg took the stand today in Los Angeles.

  • Meta, along with Google, are the defendants in a lawsuit.

  • It's the first of 3,000 cases against them,

  • saying the companies should be held liable for making social media addictive for teens.

  • Zuckerberg faced questions about his company's efforts to get more of its users' time and attention.

  • In his testimony, Zuckerberg said,

  • The Food and Drug Administration said it would review Moderna's application to sell a new seasonal flu shot.

  • It's a reversal from earlier this month when the FDA surprised the company,